Researchers use proteomics to identify six subtypes in non-small cell lung cancer associated with specific therapeutic targets and immune-evasion mechanisms and also demonstrate clinical utilization of the subtypes by mass-spectrometry based classification of late-stage lung cancer biopsies

https://ift.tt/30WvaSD via /r/science https://ift.tt/3E2jOe4